Life Sciences Tools & Services Contracts & Agreements
5,024 Contracts from 64 Life Sciences Tools & Services Companies
- 10x Genomics, Inc. (52 contracts)
- AbCellera Biologics Inc. (23)
- AbSci Corp (36)
- Adaptive Biotechnologies Corp (36)
- Agilent Technologies Inc (184)
- Akoya Biosciences, Inc. (27)
- Alpha Teknova, Inc. (44)
- ArcherDX, Inc. (22)
- ARQULE INC (83)
- ARYA Sciences Acquisition Corp III (47)
- Avantor, Inc. (39)
- Basis Global Technologies, Inc. (11)
- Berkeley Lights, Inc. (51)
- Bio-Matrix Scientific Group, Inc. (146)
- Bio-Rad Laboratories (38)
- Bio-Techne (94)
- BIOANALYTICAL SYSTEMS INC (135)
- BioNano Genomics, Inc (126)
- BRUKER CORP (54)
- Cambrex Corporation (35)
- CHAMPIONS ONCOLOGY, INC. (44)
- Charles River Laboratories (95)
- ChromaDex Corp. (174)
- CM Life Sciences II Inc. (59)
- Codex DNA, Inc. (42)
- CODEXIS INC (179)
- Cytek BioSciences, Inc. (21)
- ECO SCIENCE SOLUTIONS, INC. (65)
- EMMAUS LIFE SCIENCES, INC. (272)
- EVIO, INC. (99)
- FLUIDIGM CORP (178)
- HARVARD BIOSCIENCE INC (110)
- HighCape Capital Acquisition Corp. (67)
- Illumina Inc (127)
- INTERNATIONAL ISOTOPES INC (3)
- InventaBioTech Inc. (6)
- IQVIA Holdings Inc. (116)
- IsoPlexis Corp (32)
- Lifesci Acquisition II Corp. (49)
- Luminex Corporation (108)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (66)
- Medpace Holdings, Inc. (33)
- Mettler Toledo (38)
- Miromatrix Medical Inc. (64)
- NanoString Technologies Inc (107)
- NEOGENOMICS INC (99)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (108)
- PerkinElmer (190)
- Personalis, Inc. (64)
- Pharma-Bio Serv, Inc. (43)
- PPD, Inc. (31)
- PRA Health Sciences (57)
- PRESSURE BIOSCIENCES INC (107)
- Quanterix Corp (75)
- RAPID MICRO BIOSYSTEMS, INC. (36)
- Repligen Corporation (74)
- Seer, Inc. (36)
- SeqLL, Inc. (76)
- Singular Genomics Systems, Inc. (34)
- Sotera Health Co (38)
- Syneos Health (132)
- Thermo Fisher Scientific (238)
- VG Acquisition Corp. (59)
- Waters Corporation (90)
- Business Finance (1,868 contracts from 64 companies)
- Business Formation (1 | 1)
- Business Operations (302 | 60)
- Human Resources (1,418 | 62)
- Intellectual Property (162 | 28)
- Mergers & Acquisitions (90 | 35)
- Real Estate (210 | 37)
- Uncategorized (973 | 63)
- Exchange Agreement, dated March 18, 2024, by and between Standard BioTools Inc. and the Investors (FLUIDIGM CORP, Filed With SEC on March 18, 2024)
- Asset Purchase Agreement, dated as of March 10, 2024, by and between NanoString Technologies, Inc. and Nucleus Buyer, LLC (NanoString Technologies Inc, Filed With SEC on March 12, 2024)
- Limited Waiver and Amendment No. 5 to the Amended and Restated Credit and Security Agreement (Revolving Loan), by and among Alpha Teknova, Inc. and MidCap Financial Trust, as... (Alpha Teknova, Inc., Filed With SEC on March 11, 2024)
- Limited Waiver and Amendment No. 5 to the Amended and Restated Credit and Security Agreement (Term Loan), by and among Alpha Teknova, Inc. and MidCap Financial Trust, as agent and... (Alpha Teknova, Inc., Filed With SEC on March 11, 2024)
- Common Warrant to Purchase Common Stock of Alpha Teknova, Inc. issued to MidCap Funding XXVII on March 8, 2024 (Alpha Teknova, Inc., Filed With SEC on March 11, 2024)
- Amended and Restated Incentive Compensation Recoupment Policy (ChromaDex Corp., Filed With SEC on March 6, 2024)
- Fourth Amendment to Lease, dated December 20, 2018, by and between 10900 WILSHIRE L.L.C and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on March 6, 2024)
- Form of Common Stock Certificate (BioNano Genomics, Inc, Filed With SEC on March 5, 2024)
- Description of the Companys Securities (BioNano Genomics, Inc, Filed With SEC on March 5, 2024)
- Underwriting Agreement, dated February 28, 2024, among the Company, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., and Jefferies LLC, as... (Sotera Health Co, Filed With SEC on March 4, 2024)
- Offer Letter between the Registrant and Elona Kogan, dated November 4, 2020 (Seer, Inc., Filed With SEC on March 4, 2024)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Seer, Inc., Filed With SEC on March 4, 2024)
- Second Amended and Restated Non-Employee Director Compensation Program (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on March 1, 2024)
- Description of Capital Stock (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on March 1, 2024)
- Standard BioTools Inc. Amended and Restated Outside Director Equity Compensation Policy (FLUIDIGM CORP, Filed With SEC on March 1, 2024)
- Form of Indemnification Agreement entered into by and between Standard BioTools Inc. and certain of its officers and directors (FLUIDIGM CORP, Filed With SEC on March 1, 2024)
- First Amendment to Rapid Micro Biosystems, Inc. 2023 Inducement Plan (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on March 1, 2024)
- Description of Securities (FLUIDIGM CORP, Filed With SEC on March 1, 2024)
- Form of Performance Stock Unit Grant Notice and Performance Stock Unit Agreement (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Form of Stock Option Grant Notice and Stock Option Agreement (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- First Amendment to Credit Agreement to Credit Agreement, dated as of August 11, 2021, by Maravai Intermediate Holdings, LLC and Morgan Stanley Senior Funding, Inc (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Lease Agreement, date (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Second Amendment to Lease Agreement, dated October 1, 2022, by and between 10240 Flanders Investors LLC and Trilink Biotechnologies, LLC (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- First Amendment to Lease Agreement, dated October 14, 2021, by and between 10240 Flanders Investors LLC and Trilink Biotechnologies, LLC (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Lease Agreement, dated August 6, 2021, by and between 10240 Flanders Investors LLC and Trilink Biotechnologies, LLC (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Nonemployee Director Compensation Policy (HighCape Capital Acquisition Corp., Filed With SEC on February 29, 2024)
- Form of Restricted Stock Unit Agreement under 2021 Equity Incentive Plan (HighCape Capital Acquisition Corp., Filed With SEC on February 29, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Quanterix Corp, Filed With SEC on February 29, 2024)
- Form of Restricted Stock Unit Agreement under the 2017 Employee, Director and Consultant Equity Incentive Plan (Quanterix Corp, Filed With SEC on February 29, 2024)
- Share Purchase Agreement dated as of February 27, 2024, by and between Bruker Invest AG, and Tecfin S. r.l., Christoph Gauer, Eliman 1 and Eliman 2 (BRUKER CORP, Filed With SEC on February 29, 2024)
- Amendment No.1, effective as of (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Description of Maravai LifeSciences Holdings, Inc.s Securities (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 29, 2024)
- Description of Securities (HighCape Capital Acquisition Corp., Filed With SEC on February 29, 2024)
- Warranty Agreement dated as of February 27, 2024, by and among Bruker Invest AG, Tecfin S. r.l., Christoph Gauer, Eliman 1 and Eliman 2 (BRUKER CORP, Filed With SEC on February 29, 2024)
- Put Option Agreement, dated as of December 23, 2023, by and between Bruker Invest AG, as promisor and Tecfin S. r.l., as beneficiary (BRUKER CORP, Filed With SEC on February 29, 2024)
- Sales Agreement, dated as of February 28, 2024, between Nautilus Biotechnology, Inc. and Cowen and Company, LLC (ARYA Sciences Acquisition Corp III, Filed With SEC on February 28, 2024)
- Underwriting Agreement dated February 27, 2024 (AbSci Corp, Filed With SEC on February 28, 2024)
- Second Amended and Restated Executive Severance Agreement, dated September 18, 2023, between the Company and Stephen Moore (Personalis, Inc., Filed With SEC on February 28, 2024)
- Third Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Richard Chen (Personalis, Inc., Filed With SEC on February 28, 2024)